Inventor · disambiguated record
David Barrett
Also filed as: BARRETT DAVID · BARRETT DAVID GENE
8 granted patents·5 pending applications·53 citations·filing 1992–2022
82Inventor score
Files withFUJISAWA PHARMACEUTICAL CO5LILLY CO ELI2BARRETT DAVID GENE1SMITHKLINE BEECHAM CORP1TODA AYAKO1
Top patents by PatentIndex Score
13 records- 0181US6884868B1Cyclic hexapeptides having antibiotic activityFUJISAWA PHARMACEUTICAL CO·Filed 2000·Granted Apr 26, 2005·20 cites·8 claims
- 0269US7576108B2Substituted arylcyclopropylacetamides as glucokinase activatorsLILLY CO ELI·Filed 2003·Granted Aug 18, 2009·7 cites·18 claims
- 0363US5359066ACertain tricyclic pyrido[3,2,1-ij]cinnoline-8-carboxylates, useful as antimicrobial agentsWAKUNAGA PHARMA CO LTD·Filed 1992·Granted Oct 25, 1994·8 cites·4 claims
- 0460US6232290B1Cyclic hexapeptides with antimicrobial activityFUJISAWA PHARMACEUTICAL CO·Filed 1999·Granted May 15, 2001·18 cites·9 claims
- 0558US12037322B2AHR agonistsLILLY CO ELI·Filed 2022·Granted Jul 16, 2024·0 cites·17 claims
- 0645US2005014685A1New compoundFUJISAWA PHARMACEUTICAL CO·Filed 2004·Application pending·0 cites
- 0745US2005004014A1New compoundFUJISAWA PHARMACEUTICAL CO·Filed 2004·Application pending·0 cites
- 0844US6884774B2Cyclic hexapeptide derivativesFUJISAWA PHARMACEUTICAL CO·Filed 2001·Granted Apr 26, 2005·0 cites·13 claims
- 0942US7402606B2Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone lossSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jul 22, 2008·0 cites·46 claims
- 1040US2005181988A1Echinocandin cyclic peptide derivativesFiled 2003·Application pending·0 cites
- 1137US2005261177A1CompoundTODA AYAKO·Filed 2002·Application pending·0 cites
- 1237US2005107616A1Alpha-ketoamide derivatives as cathepsin k inhibitorsFiled 2002·Application pending·0 cites
- 1332US8207344B2GPR119 agonistsBARRETT DAVID GENE·Filed 2010·Granted Jun 26, 2012·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when David Barrett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →